277 related articles for article (PubMed ID: 36296377)
21. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes.
Sun Y; Dai C; Yin M; Lu J; Hu H; Chen D
Int J Nanomedicine; 2018; 13():1621-1632. PubMed ID: 29588589
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
23. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity.
Youssef T; Fadel M; Fahmy R; Kassab K
Pharm Dev Technol; 2012; 17(2):177-86. PubMed ID: 21047275
[TBL] [Abstract][Full Text] [Related]
25. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
Zhu M; Shi X; Gong Z; Su Q; Yu R; Wang B; Yang T; Dai B; Zhan Y; Zhang D; Zhang Y
Pharmacol Res; 2020 Aug; 158():104868. PubMed ID: 32407961
[TBL] [Abstract][Full Text] [Related]
26. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
27. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
28. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy.
Cai Y; Xu Y; Chan HF; Fang X; He C; Chen M
Mol Pharm; 2016 Mar; 13(3):699-709. PubMed ID: 26808002
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
30. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
Xu Q; Zhu T; Yi C; Shen Q
Drug Dev Ind Pharm; 2016; 42(5):701-6. PubMed ID: 26288997
[TBL] [Abstract][Full Text] [Related]
31. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
Xu Q; Zhu T; Yi C; Shen Q
Drug Dev Ind Pharm; 2016 May; 42(5):701-706. PubMed ID: 26258801
[TBL] [Abstract][Full Text] [Related]
32. Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery.
Cui L; Wang X; Liu Z; Li Z; Bai Z; Lin K; Yang J; Cui Y; Tian F
Int J Biol Macromol; 2023 Jun; 240():124370. PubMed ID: 37044320
[TBL] [Abstract][Full Text] [Related]
33. [Preparation of tanshinone Ⅱ_A-glycyrrhetinic acid solid lipid nanoparticles and its inhibitory effect on acne].
Chen FN; Wang XL; Xu RR; Wang XJ; Ruan JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2449-2456. PubMed ID: 35531692
[TBL] [Abstract][Full Text] [Related]
34. Construction of redox-sensitive liposomes modified by glycyrrhetinic acid and evaluation of anti-hepatocellular carcinoma activity.
Hu J; Zheng Y; Wen Z; Fu H; Yang X; Ye X; Zhu S; Kang L; Li X; Yang X; Hu Y
Chem Phys Lipids; 2023 May; 252():105292. PubMed ID: 36931583
[TBL] [Abstract][Full Text] [Related]
35. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
Wang X; Gu X; Wang H; Yang J; Mao S
Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
[TBL] [Abstract][Full Text] [Related]
36. Capsaicin-loaded solid lipid nanoparticles: design, biodistribution, in silico modeling and in vitro cytotoxicity evaluation.
Kunjiappan S; Sankaranarayanan M; Karan Kumar B; Pavadai P; Babkiewicz E; Maszczyk P; Glodkowska-Mrowka E; Arunachalam S; Ram Kumar Pandian S; Ravishankar V; Baskararaj S; Vellaichamy S; Arulmani L; Panneerselvam T
Nanotechnology; 2021 Feb; 32(9):095101. PubMed ID: 33113518
[TBL] [Abstract][Full Text] [Related]
37. Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity.
Xue H; Qin L; Zhang L; Li X; Wu F; Wang W; Wang C; Diao W; Jiang B; Lian B; Wu J; Bai J; Sun T; Zhao C; Qu M; Yu W; Wang Y; Gao Z
Exp Ther Med; 2021 Oct; 22(4):1144. PubMed ID: 34471430
[TBL] [Abstract][Full Text] [Related]
38. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
39. Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles.
Wang H; Sun S; Zhang Y; Wang J; Zhang S; Yao X; Chen L; Gao Z; Xie B
Drug Deliv; 2019 Dec; 26(1):89-97. PubMed ID: 30744448
[TBL] [Abstract][Full Text] [Related]
40. A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability.
Oner E; Kotmakci M; Kantarci AG
Pharm Dev Technol; 2020 Oct; 25(8):936-948. PubMed ID: 32315242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
